Q2 2020 Holdings
Filed 2020-08-14 | 15 holdings | $139.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc.(ARQT) | COM | 03969K108 | $120.3M | 3,979,292 | 86.0% |
| Crinetics Pharmaceuticals, Inc.(CRNX) | COM | 22663K107 | $18.8M | 1,071,428 | 13.4% |
| Springworks Therapeutics Inc | COM | 85205L107 | $305.8K | 7,281,307 | 0.2% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $103.6K | 4,080,237 | 0.1% |
| Dynavax Technologies Corp.(DVAX) | COM | 268158201 | $96.6K | 10,895,773 | 0.1% |
| Mersana Therapeutics, Inc. | COM | 59045L106 | $80.6K | 3,445,667 | 0.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $53.7K | 2,162,598 | 0.0% |
| Constellation Pharmaceuticals Inc.(CNST) | COM | 210373106 | $42.1K | 1,400,000 | 0.0% |
| Aeglea Biotherapeutics, Inc.(AGLEUSD) | COM | 00773J103 | $25.0K | 2,700,000 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $23.2K | 5,558,425 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $23.0K | 5,128,593 | 0.0% |
| Sage Therapeutics, Inc.(SG7) | COM | 78667J108 | $20.8K | 499,100 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $15.4K | 1,648,485 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $14.5K | 5,724,235 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $11.3K | 3,871,164 | 0.0% |